Interstitial myositis affecting a muscle site that is not specified in the clinical documentation — use only when the affected anatomic location cannot be determined or was not documented.

Documentation tips

What should appear in the chart to support M60.10.

Source · Editorial brief grounded in 5 cited references ↓

• Document the specific muscle group or body region affected by name — shoulder, thigh, lower leg, etc. — so a site-specific M60.1x code can be assigned instead of this unspecified fallback.
• Record the clinical basis for the interstitial (non-infective) pattern: absence of purulent drainage, negative culture, chronicity of symptoms, or biopsy findings showing connective tissue inflammation around intact fibers.
• If imaging (MRI) or biopsy was performed, include the report findings in the note — fat infiltration, perimysial fibrosis, or signal changes anchor the diagnosis and support medical necessity.
• Distinguish explicitly from polymyositis (M33.2) and inclusion body myositis (G72.41) in the assessment; payers may request evidence that autoimmune or IBM etiologies were ruled out.
• When EMG or nerve conduction studies are ordered alongside this diagnosis, the ordering note must link the study to the suspected muscle pathology at a named anatomic location to satisfy LCD requirements.

Related CPT procedures

Procedure codes commonly billed with M60.10. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M60.10 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Assigning M60.10 when the note does document a body region — always review the full assessment and physical exam before using the unspecified-site code.
• Confusing interstitial myositis (M60.1x) with infective myositis (M60.0x) — if the provider documented a causative organism or positive culture, M60.0x with a pathogen code (e.g., B95.61 for S. aureus) is correct.
• Coding M60.10 for inclusion body myositis — IBM is explicitly excluded from M60 by a Type 2 Excludes note; use G72.41 when biopsy confirms rimmed vacuoles.
• Using M60.10 as the primary diagnosis for a trigger point injection without confirming it appears on the applicable MAC LCD — many LCDs list site-specific M60.8xx codes but not M60.10 for trigger point medical necessity.
• Forgetting that M60.1 (parent) is non-billable — only the child codes, including M60.10, are valid for claim submission.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M60.1 (laterality / anatomic variants).